Leveraging Telehealth to Optimize PrEP and PEP Delivery at Pharmacies in Kenya
Sponsor: Fred Hutchinson Cancer Center
Trial Details
| Condition | HIV |
| Intervention | Telehealth delivery of pharmacy PrEP/PEP; Standard pharmacy PrEP/PEP delivery |
| Phase | NA |
| Status | Not_yet_recruiting |
| Participants | 1,580 |
| Est. Completion | 31 Mar 2028 |
| Last Updated | 11 May 2026 |
Primary Outcome
PrEP/PEP initiations; PrEP/PEP continuation
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: Pharmacies * Registered with the Pharmacy and Poisons Board (PPB) * Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff * Must have a private room where HIV testing and PrEP/PEP counseling can occur * \>3 km from other study pharmacies * Willing to participate in research activities, including 2-day training for pharmacy providers * Willing to share pharmacy records with us * Sells HIVST kits that are WHO certified. Pharmacists/remote nurses * ≥ 18 years old * Licensed pharmacist, pharmaceutical technologist, or nurse * Willing to provide PrEP and PEP services, including HIV testing and associated counseling services * Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing * Able and willing to provide informed consent Clients * ≥ 15 years old * Interested in being screened for PrEP or PEP * Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety * Able and willing to provide informed consent Exclusion Criteria: Clients * Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information * Currently enrolled in any other HIV vaccine or prevention trial * Have a condition that would preclude provision of informed consent, make study participation unsafe, complicate interpretation of outcome data, or otherwise interfere with achieving study objectives
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service